We just got more 'hopeful' data on Gilead's potential coronaviru

https://www.businessinsider.com/gilead-remdesivir-clinical-data-in-covid-19-patients-2020-4

We just got more 'hopeful' data on Gilead's potential coronavirus treatment, but it's too soon to tell if the drug works

 

• More than two-thirds of hospitalized COVID-19 patients improved in condition after receiving remdesivir, an experimental antiviral treatment from Gilead Sciences. 
• These findings come from data published Friday on 53 patients, the largest dataset yet for remdesivir.
• Experts, including the lead author of this study, cautioned against reaching conclusions on the drug's efficacy. This is because the trial had no control arm to compare the results with. 
• High-quality data is coming soon from two studies in China that tested remdesivir against a placebo. Those results are anticipated this month. 
• Visit Business Insider's homepage for more stories.

所有跟帖： 

• 这是一个良心企业，感谢rimm推荐，大叔手里唯一一个过去几个月不跌反涨的股票。 -卒在征途- ♂ (348 bytes) () 04/10/2020 postreply 17:44:25